Skip to content

Clinical trials

Hypertension trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: Puerto Rico Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20084
20102
20112
20122
20133
20161
20171
20192
20211
20221
20232
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting5
Recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Eli Lilly and Company4
Harvard School of Public Health (HSPH)3
Alnylam Pharmaceuticals2
Forest Laboratories2
GlaxoSmithKline2
Mineralys Therapeutics Inc.2
Takeda2
Aphaia Pharma US LLC1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension33
Diabetes Mellitus, Type 27
Obesity7
Cardiovascular Diseases5
Diabetes Mellitus3
Dyslipidemias3
Essential Hypertension3
Hyperglycemia3
Heart Failure2
Hypertriglyceridemia2

Trials

Showing 26 to 33 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.